Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Beta-adrenergic receptor blockers decrease intravenous anesthetic dose requirements. The present study determined the effect of propranolol on indocyanine green and antipyrine disposition from the moment of rapid intravenous injection. Anti-pyrine is a physiological marker that distributes to a volume as large as total body water in a blood flow-dependent manner and is a pharmacokinetic surrogate for many lipophilic drugs, including intravenous anesthetics. Antipyrine and indocyanine green disposition were determined twice in five healthy adult males in this Institutional Review Board-approved study, once during propranolol infusion. After rapid indocyanine green and antipyrine injection, arterial blood samples were collected frequently for 2 min and less frequently thereafter. Plasma indocyanine green and antipyrine concentrations were measured by high-performance liquid chromatography. Indocyanine green and antipyrine disposition were characterized, using SAAM II, by a recirculatory pharmacokinetic model that describes drug disposition from the moment of injection. Parameters were compared using the paired t test. The disposition of indocyanine green demonstrated that propranolol decreased cardiac output at the expense of the fast peripheral (nonsplanchnic) intravascular circuit. The area under the antipyrine concentration versus time relationship was doubled for at least the first 3 min after injection due to both decreased cardiac output and maintenance of nondistributive blood flow at the expense of a two-thirds reduction of blood flow (intercompartmental clearance) to the rapidly equilibrating (fast, splanchnic) tissue volume. The increase in antipyrine area under the curve due to propranolol-induced alteration of initial antipyrine disposition could explain decreased intravenous anesthetic dose requirements in the presence of beta-adrenergic receptor blockade.
Avram
Michael J
MJ
Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Avenue, Ward Bldg. 13-199, Chicago, IL 60611-3008, USA. mja190@northwestern.edu
Krejcie
Tom C
TC
Henthorn
Thomas K
TK
Niemann
Claus U
CU
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics; D000983:Antipyrine / Q000493:pharmacokinetics*; D002302:Cardiac Output / Q000502:physiology*; D004347:Drug Interactions; D006801:Humans; D007208:Indocyanine Green / Q000493:pharmacokinetics*; D008297:Male; D011433:Propranolol / Q000494:pharmacology*; D012039:Regional Blood Flow
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D011433:Propranolol; D007208:Indocyanine Green; D000983:Antipyrine